Clinical trial
A Study to Investigate the Relative Pharmacological Activity of Aninhaled B2-agonist/Anticholinergic Dual Pharmacophore Inhealthy Volunteers
NCT00687700 is registered in ClinicalTrials.gov with Theravance Biopharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Investigate the Relative Pharmacological Activity of Aninhaled B2-agonist/Anticholinergic Dual Pharmacophore Inhealthy Volunteers
- Lead sponsor
- Theravance Biopharma
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 10, 2008
- Completion date
- May 27, 2008
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.